[Namestin (Clonidine), 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in the treatment of essential hypertension (author's transl)].
D001794:Blood Pressure / Q000187:drug effects; D002712:Chlorides / Q000097:blood; D002986:Clinical Trials as Topic; D003000:Clonidine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D014508:Urea / Q000097:blood; D014717:Vertigo / Q000139:chemically induced
D002712:Chlorides; D014508:Urea; D012964:Sodium; D003404:Creatinine; D003000:Clonidine; D009584:Nitrogen; D011188:Potassium
Namestin (Clonidin, 2-(2,6-Dichlorphenylamino)-2-imidazolinhydrochlorid) in der Behandlung der essentiellen Hypertonie